Hyliion Holdings Corp. $HYLN Stock Holdings Lifted by 683 Capital Management LLC

Key Points

• 683 Capital Management LLC increased its stake in Hyliion Holdings Corp. by 171.4%, owning 950,000 shares worth approximately $1.33 million after purchasing an additional 600,000 shares in the first quarter.
• Several institutional investors have also increased their holdings, with Dimensional Fund Advisors LP significantly boosting its position by 628.8% during the fourth quarter.
• Hyliion's stock is currently rated as a "Hold" by analysts, with recent price performance showing a 2.3% decline and shares trading at $1.68.

683 Capital Management LLC raised its position in Hyliion Holdings Corp. (NYSE:HYLN - Free Report) by 171.4% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 950,000 shares of the company's stock after purchasing an additional 600,000 shares during the quarter. 683 Capital Management LLC owned approximately 0.54% of Hyliion worth $1,330,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of HYLN. Wells Fargo & Company MN grew its stake in Hyliion by 35.7% in the fourth quarter. Wells Fargo & Company MN now owns 93,123 shares of the company's stock valued at $243,000 after purchasing an additional 24,474 shares in the last quarter. Raymond James Financial Inc. acquired a new stake in shares of Hyliion in the fourth quarter worth about $43,000. Barclays PLC lifted its position in shares of Hyliion by 13.6% in the fourth quarter. Barclays PLC now owns 209,806 shares of the company's stock worth $547,000 after buying an additional 25,121 shares during the last quarter. Dimensional Fund Advisors LP lifted its position in shares of Hyliion by 628.8% in the fourth quarter. Dimensional Fund Advisors LP now owns 513,927 shares of the company's stock worth $1,335,000 after buying an additional 443,412 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD lifted its position in shares of Hyliion by 11.0% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 121,536 shares of the company's stock worth $318,000 after buying an additional 12,007 shares during the last quarter. Hedge funds and other institutional investors own 22.81% of the company's stock.

Insiders Place Their Bets

In other Hyliion news, Director Richard Joseph Freeland bought 65,000 shares of the firm's stock in a transaction that occurred on Thursday, August 21st. The stock was purchased at an average price of $1.57 per share, for a total transaction of $102,050.00. Following the purchase, the director directly owned 222,798 shares in the company, valued at $349,792.86. This trade represents a 41.19% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 20.90% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the company. Zacks Research raised Hyliion from a "strong sell" rating to a "hold" rating in a research report on Wednesday, August 13th. Wall Street Zen cut Hyliion from a "hold" rating to a "sell" rating in a research report on Sunday, August 24th. Two analysts have rated the stock with a Hold rating, According to MarketBeat.com, the company has a consensus rating of "Hold".

Hyliion Stock Down 2.3%

Shares of NYSE:HYLN opened at $1.68 on Tuesday. The business has a 50 day moving average price of $1.55 and a 200 day moving average price of $1.53. Hyliion Holdings Corp. has a twelve month low of $1.11 and a twelve month high of $4.10. The company has a market cap of $294.73 million, a price-to-earnings ratio of -4.54 and a beta of 2.31.

About Hyliion

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.